Article from March 2021

Canada has signed a contract with Novavax that states the company will provide 52 million doses of its vaccine candidate with an option to purchase 24 million more, and that deliveries will take place monthly to fulfill quarterly allotments — once it gets approved for use in Canada. Canada has inked a deal to have the vaccine made in-house, but likely won’t be able to begin manufacturing its own before the end of the year.”


Novavax filings give first glimpse of deal Canada made for COVID-19 vaccines